WHC is still in active development. Read this to understand our approach.
depiction of UFLGIAIHIAPJJC-UHFFFAOYSA-N.svg
isomerdesign

Tripelennamine

Verificar en isomerdesign

pubchem

Tripelennamine

Verificar en pubchem

drugmap

Tripelennamine

Verificar en drugmap

wiki

Tripelennamine

Verificar en wiki

Data

InChI: InChI=1S/C16H21N3/c1-18(2)12-13-19(16-10-6-7-11-17-16)14-15-8-4-3-5-9-15/h3-11H,12-14H2,1-2H3

Sinónimos: KBio2_005757,1, N,N-dimethyl-N'-(phenylmethyl)-N'-2-pyridinyl-,Q415203,NCI-C60662,KBioGR_000867, Tripelennamine [BAN],N,N-Dimethyl-N'-(phenylmethyl)-N'-2-pyridinyl-1,2-ethanediamine, Tripelennamine [INN], Pyristine (piristina), Tripelennamina, Resistamine,2-(benzyl(2-(dimethylamino)ethyl)amino)pyridine, Benzyl-(alpha-pyridyl)-dimethylaethylendiamin [German], Benzyl-(alpha.-pyridyl)-dimethylaethylendiamin,Tripellenamine,Cizaron, Piribenzil, Tripelenamina [INN-Spanish], Vetibenzamina, 2-(Benzyl(2-dimethylaminoethyl)amino)pyridine,NCGC00018125-02,Tripelennamine, Pyrinamine base,BRN 0227074,Tripelennamine [INN],Pyridine, 2-(benzyl(2-(dimethylamino)ethyl)amino)-,Tripelennamin,Tripelenamina [INN-Spanish],Spectrum3_001696, Tripelennaminum, N,N-Dimethyl-N'-benzyl-N'-(2-pyridyl)ethylenediamine,Benzyl-(alpha-pyridyl)-dimethylaethylendiamin [German],WLN: T6NJ BN1R&2N1&1,AB00053562_13,beta-Dimethylaminoethyl-2-pyridylbenzylamine,Benzyl-.alpha.-pyridyl-dimethyl-aethylendiamin,Pbz-Sr,Dehistin (Salt/Mix),KBioSS_000621,Tripelenamina,KBio2_003189,CHEBI:9741, Tripelennaminum [INN-Latin], Tripelenamina,SPBio_000954,ZINC19117728, Tripelennamine Citrate (1:1), 2-(N-Benzyl-N-(2-dimethylaminoethyl)amino)pyridine, N,N-Dimethyl-N'-benzyl-N'-(alpha.-pyridyl)ethylenediamine,CAS_91-81-6,GTPL7318,N-Benzyl-N-(2-pyridyl)-N',N'-dimethyl ethylenediamine,N,N-dimethyl-N'-(phenylmethyl)-N'-pyridin-2-ylethane-1,2-diamine,Pyridbenzamine,N-Benzyl-N',N'-dimethyl-N-2-pyridylethylenediamine,Spectrum4_000374,Benzyl-(.alpha.-pyridyl)-dimethylaethylendiamin,Pyribenzamin, Pyribenzamin,NCGC00018125-03,DTXSID8023717,Tri-Tumine (Salt/Mix), Benzyl-(alpha-pyridyl)-dimethylaethylendiamin, N-Benzyl-N-(2-pyridyl)-N',N'-dimethyl ethylenediamine,D08645,TRIPELENNAMINE [WHO-DD],Oprea1_266730,Pyrinamine base,SCHEMBL17970,N-benzyl-N-[2-(dimethylamino)ethyl]pyridin-2-amine,NSC118946,CS-0009189, Pyribenzamine (TN),Tonaril, Tripellenamine,BSPBio_003252,beta-Dimethylaminoethyl-2-pyridylaminotoluene,N'-benzyl-N,N-dimethyl-N'-pyridin-2-ylethane-1,2-diamine,TRIPELENNAMINE [VANDF], N-Benzyl-N',N'-dimethyl-N-2-(pyridylethylene)diamine,Tripelennaminum [INN-Latin],IDI1_000534,N,N-Dimethyl-N'-benzyl-N'-(2-pyridyl)ethylenediamine,Triplennamine,5-22-08-00378 (Beilstein Handbook Reference),CHEMBL1241,Ethylenediamine, N-benzyl-N',N'-dimethyl-N-(2-pyridyl)-, N'-benzyl-N,N-dimethyl-N'-pyridin-2-ylethane-1,2-diamine,TRIPELENNAMINE [MI],Pyridine, 2-[benzyl[2-(dimethylamino)ethyl]amino]-,Tripelennamina [Italian], N,N-dimethyl-N'-(phenylmethyl)-N'-pyridin-2-ylethane-1,2-diamine,UNII-3C5ORO99TY, Triplennamine,NSC 118946,Spectrum5_001581,KBio3_002472,Tripelennamina, 1,2-Ethanediamine, N,N-dimethyl-N'-(phenylmethyl)-N'-2-pyridinyl-(9CI), 2-(benzyl(2-(dimethylamino)ethyl)amino)pyridine,2-[Benzyl(2-dimethylaminoethyl)amino]pyridine,DB00792,Piribenzil,EINECS 202-100-1,N-Benzyl-N',N'-dimethyl-N-(2-pyridyl)ethylenediamine,.beta.-Dimethylaminoethyl-2-pyridylbenzylamine,NINDS_000534, 2-[N-Benzyl-N-(2-dimethylaminoethyl)amino]pyridine,Spectrum_000141,Resistamine,3C5ORO99TY,2-[N-Benzyl-N-(2-dimethylaminoethyl)amino]pyridine,NCGC00018125-01,2-(N-Benzyl-N-(2-dimethylaminoethyl)amino)pyridine, Cizaron,BRD-K57033106-048-02-8,Pyristine (piristina), Tripelennamin,WLN: T6NJ BN1R&2N1&1 &GH,NSC_5587,N-Benzyl-N',N'-dimethyl-N-2-(pyridylethylene)diamine,Benzyl-(alpha-pyridyl)-dimethylaethylendiamin,HSDB 5191, Ts and Blues,Tripelennamine [INN:BAN],SBI-0051548.P002,AB00053562_14,N,N-Dimethyl-N'-benzyl-N'-(alpha-pyridyl)ethylenediamine,C07180, Tonaril,.beta.-Dimethylaminoethyl-2-pyridylaminotoluene,Tripelennamine (INN),DivK1c_000534, N-Benzyl-N',N'-Dimethyl-N-Pyridin-2-Yl-Ethane-1,2-Diamine Hydrochloride,L000603,tripelennamine,Tripelannamine,N-Benzyl-N',N'-dimethyl-N-pyridin-2-ylethane-1,2-diamine,Stanzamine (Salt/Mix),Spectrum2_000957,ReCovr (Salt/Mix), N-Benzyl-N',N'-dimethyl-N-(2-pyridyl)ethylenediamine, Dehistin,BRD-K57033106-048-03-6,2750 R.P., Pyribenzamine, N,N-Dimethyl-N'-(phenylmethyl)-N'-2-pyridinyl-1,2-ethanediamine, Tripelenamine,1,2-Ethanediamine,N1,N1-dimethyl-N2-(phenylmethyl)-N2-2-pyridinyl-, 2-[Benzyl(2-dimethylaminoethyl)amino]pyridine, Beta-Dimethylaminoethyl-2-pyridylbenzylamine,HY-17428A, N-Benzyl-N',N'-dimethyl-N-2-pyridylethylenediamine,Ts and Blues, N,N-Dimethyl-N'-benzyl-N'-(alpha-pyridyl)ethylenediamine,KBio2_000621, Tripelennamine (INN),Pyribenzamine, Beta-Dimethylaminoethyl-2-pyridylaminotoluene,Tripelenamine,2-(Benzyl(2-dimethylaminoethyl)amino)pyridine,91-81-6, N-benzyl-N-[2-(dimethylamino)ethyl]pyridin-2-amine,1,2-Ethanediamine, N,N-dimethyl-N'-(phenylmethyl)-N'-2-pyridinyl-,N'-benzyl-N,N-dimethyl-N'-pyridin-2-ylethane-1,2-diamine;hydron;chloride, Benzyl-.alpha.-pyridyl-dimethyl-aethylendiamin,N,N-Dimethyl-N'-benzyl-N'-(.alpha.-pyridyl)ethylenediamine,EN300-708778, Tripelennamina [Italian], Tripelannamine,Benzoxale,Tripelennaminum,Ahistamin (Salt/Mix),N\'-benzyl-N,N-dimethyl-N\'-pyridin-2-ylethane-1,2-diamine,TRIPELENNAMINE [HSDB],NSC-118946, Pyridbenzamine,KBio1_000534,BDBM81471,AntiAllergicum Medivet (Salt/Mix)

Estimated data

Solubilidad: -2.117 (log(S) in mol/L prediction using SolTranNet)

Blood Brain Barrier Permeability: Yes (prediction using frontiersin.org)

Addictivity Prediction: 45.7% (prediction based on www.mdpi.com)

Similitudes

The following is a set of comparisons to understand the properties of this compound. This is still higly experimental and is still under active development. Please refer to our series of blog posts to fully understand our approach and its limitations. This information is for informational purposes only and should not be construed as medical advice.